Metabolically healthy and unhealthy obesity in erectile dysfunction and male infertility

References

• NCD Risk Factor Collaboration (NCD-RisC). Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants. Lancet. 2016;387:1377–1396.
   PubMed Web of Science ®Google Scholar
• Puhl RM, Heuer CA. The stigma of obesity: a review and update. Obesity (Silver Spring). 2009;17:941–964.
   PubMed Web of Science ®Google Scholar
• Schwingshackl L, Hoffmann G, Lampousi AM, et al. Food groups and risk of type 2 diabetes mellitus: a systematic review and meta-analysis of prospective studies. Eur J Epidemiol. 2017;32:363–375.
   PubMed Web of Science ®Google Scholar
• Becerra-Tomás N, Blanco Mejía S, Viguiliouk E, et al. Mediterranean diet, cardiovascular disease and mortality in diabetes: a systematic review and meta-analysis of prospective cohort studies and randomized clinical trials. Crit Rev Food Sci Nutr. 2019;24:1–21.
   Web of Science ®Google Scholar
• Bocquier A, Verger P, Basdevant A, et al. Overweight and obesity: knowledge, attitudes, and practices of general practitioners in France. Obes Res. 2005;13:787–795.
   PubMedGoogle Scholar
• Puhl RM, Phelan SM, Nadglowski J, et al. Overcoming weight bias in the management of patients with diabetes and obesity. Clin Diabetes. 2016;34:44–50.
   PubMedGoogle Scholar
• Stefan N, Häring HU, Schulze MB. Metabolically healthy obesity: the low-hanging fruit in obesity treatment? Lancet Diabetes Endocrinol. 2018;6:249–258.
   PubMed Web of Science ®Google Scholar
• Stefan N, Häring HU, Hu FB, et al. Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications. Lancet Diabetes Endocrinol. 2013;1:152–162.
   PubMed Web of Science ®Google Scholar
• Lavie CJ, Laddu D, Arena R, et al. Reprint of: healthy weight and obesity prevention: JACC health promotion series. J Am Coll Cardiol. 2018;72:3027–3052.
   PubMed Web of Science ®Google Scholar
• van Vliet-Ostaptchouk JV, Nuotio ML, Slagter SN, et al. The prevalence of metabolic syndrome and metabolically healthy obesity in Europe: a collaborative analysis of ten large cohort studies. BMC Endocr Disord. 2014;14:9.
   PubMed Web of Science ®Google Scholar
• Wildman RP, Muntner P, Reynolds K, et al. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999–2004). Arch Intern Med. 2008;168:1617–1624.
   PubMed Web of Science ®Google Scholar
• Appleton SL, Seaborn CJ, Visvanathan R, et al. Diabetes and cardiovascular disease outcomes in the metabolically healthy obese phenotype: a cohort study. Diabetes Care. 2013;36:2388–2394.
   PubMed Web of Science ®Google Scholar
• Bell JA, Hamer M, Sabia S, et al. The natural course of healthy obesity over 20 years. J Am Coll Cardiol. 2015;65:101–102.
   PubMed Web of Science ®Google Scholar
• Corona G, Monami M, Boddi V, et al. Is obesity a further cardiovascular risk factor in patients with erectile dysfunction? J Sex Med. 2010;7:2538–2546.
   PubMed Web of Science ®Google Scholar
• Corona G, Rastrelli G, Filippi S, et al. Erectile dysfunction and central obesity: an Italian perspective. Asian J Androl. 2014;16:581–591.
   PubMed Web of Science ®Google Scholar
• Corona G, Bianchini S, Sforza A, et al. Hypogonadism as a possible link between metabolic diseases and erectile dysfunction in aging men. Hormones (Athens). 2015;14:569–578.
   PubMedGoogle Scholar
• Glina FPA, de FreitasBarboza JW, Nunes VM, et al. What is the impact of bariatric surgery on erectile function? A systematic review and meta-analysis. Sex Med Rev. 2017;5:393–402.
   PubMedGoogle Scholar
• Corona G, Rastrelli G, Monami M, et al. Body weight loss reverts obesity-associated hypogonadotropic hypogonadism: a systematic review and meta-analysis. Eur J Endocrinol. 2013;168:829–843.
   PubMed Web of Science ®Google Scholar
• Zomer E, Gurusamy K, Leach R, et al. Interventions that cause weight loss and the impact on cardiovascular risk factors: a systematic review and meta-analysis. Obes Rev. 2016;17:1001–1011.
   PubMed Web of Science ®Google Scholar
• Campbell JM, Lane M, Owens JA, et al. Paternal obesity negatively affects male fertility and assisted reproduction outcomes: a systematic review and meta-analysis. Reprod Biomed Online. 2015;31:593–604.
   PubMed Web of Science ®Google Scholar
• Sims EA. Are there persons who are obese, but metabolically healthy? Metabolism. 2001;50:1499–1504.
   PubMed Web of Science ®Google Scholar
• Aguilar-Salinas CA, Garcia EG, Robles L, et al. High adiponectin concentrations are associated with the metabolically healthy obese phenotype. J Clin Endocrinol Metab. 2008;93:4075–4079.
   PubMed Web of Science ®Google Scholar
• Karelis AD, Brochu M, Rabasa-Lhoret R. Can we identify metabolically healthy but obese individuals (MHO)? Diabetes Metab. 2004;30:569–572.
   PubMed Web of Science ®Google Scholar
• Meigs JB, Wilson PW, Fox CS, et al. Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J Clin Endocrinol Metab. 2006;91:2906–2912.
   PubMed Web of Science ®Google Scholar
• Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001;285:2486–2497.
   PubMed Web of Science ®Google Scholar
• Stefan N, Kantartzis K, Machann J, et al. Identification and characterization of metabolically benign obesity in humans. Arch Intern Med. 2008;168:1609–1616.
   PubMed Web of Science ®Google Scholar
• Wilson PW, D’Agostino RB, Sullivan L, et al. Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch Intern Med. 2002;162:1867–1872.
   PubMed Web of Science ®Google Scholar
• Abdullah A, Wolfe R, Stoelwinder JU, et al. The number of years lived with obesity and the risk of all-cause and cause-specific mortality. Int J Epidemiol. 2011;40:985–996.
   PubMed Web of Science ®Google Scholar
• Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364:937–952.
   PubMed Web of Science ®Google Scholar
• McGee DL; Diverse Populations Collaboration. Body mass index and mortality: a meta-analysis based on person-level data from twenty-six observational studies. Ann Epidemiol. 2005;15:87–97.
   PubMed Web of Science ®Google Scholar
• Abell JE, Egan BM, Wilson PW, et al. Differences in cardiovascular disease mortality associated with body mass between Black and White persons. Am J Public Health. 2008;98:63–66.
   PubMed Web of Science ®Google Scholar
• Czernichow S, Kengne AP, Stamatakis E, et al. Body mass index, waist circumference and waist-hip ratio: which is the better discriminator of cardiovascular disease mortality risk?: evidence from an individual-participant meta-analysis of 82 864 participants from nine cohort studies. Obes Rev. 2011;12:680–687.
   PubMed Web of Science ®Google Scholar
• Kwon Y, Kim HJ, Park S, et al. Body mass index-related mortality in patients with type 2 diabetes and heterogeneity in obesity paradox studies: a dose-response meta-analysis. PLoS One. 2017;12:e0168247.
   PubMed Web of Science ®Google Scholar
• Fan J, Song Y, Chen Y, et al. Combined effect of obesity and cardio-metabolic abnormality on the risk of cardiovascular disease: a meta-analysis of prospective cohort studies. Int J Cardiol. 2013;168:4761–4768.
   PubMed Web of Science ®Google Scholar
• Kramer CK, Zinman B, Retnakaran R. Are metabolically healthy overweight and obesity benign conditions?: a systematic review and meta-analysis. Ann Intern Med. 2013;159:758–769.
   PubMed Web of Science ®Google Scholar
• Eckel N, Meidtner K, Kalle-Uhlmann T, et al. Metabolically healthy obesity and cardiovascular events: a systematic review and meta-analysis. Eur J Prev Cardiol. 2016;23:956–966.
   PubMed Web of Science ®Google Scholar
• Zheng R, Zhou D, Zhu Y. The long-term prognosis of cardiovascular disease and all-cause mortality for metabolically healthy obesity: a systematic review and meta-analysis. J Epidemiol Community Health. 2016;70:1024–1031.
   PubMed Web of Science ®Google Scholar
• Stefan N, Schick F, Häring HU. Causes, characteristics, and consequences of metabolically unhealthy normal weight in humans. Cell Metab. 2017;26:292–300.
   PubMed Web of Science ®Google Scholar
• Montorsi P, Ravagnani PM, Galli S, et al. The artery size hypothesis: a macrovascular link between erectile dysfunction and coronary artery disease. Am J Cardiol. 2005;96:19M–23M.
   PubMed Web of Science ®Google Scholar
• Guo W, Liao C, Zou Y, et al. Erectile dysfunction and risk of clinical cardiovascular events: a meta-analysis of seven cohort studies. J Sex Med. 2010;7:2805–2816.
   PubMed Web of Science ®Google Scholar
• Dong JY, Zhang YH, Qin LQ. Erectile dysfunction and risk of cardiovascular disease: meta-analysis of prospective cohort studies. J Am Coll Cardiol. 2011;58:1378–1385.
   PubMed Web of Science ®Google Scholar
• Vlachopoulos CV, Terentes-Printzios DG, Ioakeimidis NK, et al. Prediction of cardiovascular events and all-cause mortality with erectile dysfunction: a systematic review and meta-analysis of cohort studies. Circ Cardiovasc Qual Outcomes. 2013;6:99–109.
   PubMed Web of Science ®Google Scholar
• Fan Y, Hu B, Man C, et al. Erectile dysfunction and risk of cardiovascular and all-cause mortality in the general population: a meta-analysis of cohort studies. World J Urol. 2018;36:1681–1689.
   PubMed Web of Science ®Google Scholar
• Yamada T, Hara K, Umematsu H, et al. Erectile dysfunction and cardiovascular events in diabetic men: a meta-analysis of observational studies. PLoS One. 2012;7:e43673.
   PubMed Web of Science ®Google Scholar
• Fillo J, Levcikova M, Ondrusova M, et al. Importance of different grades of abdominal obesity on testosterone level, erectile dysfunction, and clinical coincidence. Am J Mens Health. 2017;11:240–245.
   PubMed Web of Science ®Google Scholar
• Han TS, Tajar A, O’Neill TW, et al. Impaired quality of life and sexual function in overweight and obese men: the European Male Ageing Study. Eur J Endocrinol. 2011;164:1003–1011.
   PubMed Web of Science ®Google Scholar
• Corona G, Lee DM, Forti G, et al. Age-related changes in general and sexual health in middle-aged and older men: results from the European Male Ageing Study (EMAS). J Sex Med. 2010;7:1362–1380.
   PubMed Web of Science ®Google Scholar
• Andersen I, Heitman BL, Wagner G, et al. Obesity and sexual dysfunction in younger Danish men. J Sex Med. 2008;5:2053–2060.
   PubMed Web of Science ®Google Scholar
• Derby CA, Mohr BA, Goldstein I, et al. Modifiable risk factors and erectile dysfunction: can lifestyle changes modify risk? Urology. 2000;56:302–306.
   PubMed Web of Science ®Google Scholar
• Fung MM, Bettencourt R, Barrett-Connor E. Heart disease risk factors predict erectile dysfunction 25 years later. J Am Coll Cardiol. 2004;43:1405–1411.
   PubMed Web of Science ®Google Scholar
• Shiri R, Koskimäki J, Hakama M, et al. Effect of life-style factors on incidence of erectile dysfunction. Int J Impot Res. 2004;16:389–394.
   PubMed Web of Science ®Google Scholar
• Camacho EM, Huhtaniemi IT, O’Neill TW, et al. Age-associated changes in hypothalamic-pituitary-testicular function in middle-aged and older men are modified by weight change and lifestyle factors: longitudinal results from the European Male Ageing Study. Eur J Endocrinol. 2013;168:445–455.
   PubMed Web of Science ®Google Scholar
• Rastrelli G, O’Neill TW, Ahern T, et al. Symptomatic androgen deficiency develops only when both total and free testosterone decline in obese men who may have incident biochemical secondary hypogonadism: prospective results from the EMAS. Clin Endocrinol (Oxf). 2018;89:459–469.
   PubMed Web of Science ®Google Scholar
• Rastrelli G, Carter EL, Ahern T, et al. Development of and recovery from secondary hypogonadism in aging men: prospective results from the EMAS. J Clin Endocrinol Metab. 2015;100:3172–3182.
   PubMed Web of Science ®Google Scholar
• Filippi S, Vignozzi L, Morelli A, et al. testosterone partially ameliorates metabolic profile and erectile responsiveness to PDE5 inhibitors in an animal model of male metabolic syndrome. J Sex Med. 2009;6:3274–3288.
   PubMed Web of Science ®Google Scholar
• Morelli A, Filippi S, Comeglio P, et al. Physical activity counteracts metabolic syndrome-induced hypogonadotropic hypogonadism and erectile dysfunction in the rabbit. Am J Physiol Metab. 2019;316:E519–35.
   PubMed Web of Science ®Google Scholar
• Vignozzi L, Morelli A, Filippi S, et al. Farnesoid X receptor activation improves erectile function in animal models of metabolic syndrome and diabetes. J Sex Med. 2011;8:57–77.
   PubMed Web of Science ®Google Scholar
• Allen MS, Walter EE. Health-related lifestyle factors and sexual dysfunction: a meta-analysis of population-based research. J Sex Med. 2018;15:458–475.
   PubMed Web of Science ®Google Scholar
• Corona G, Vignozzi L, Sforza A, et al. Obesity and late-onset hypogonadism. Mol Cell Endocrinol. 2015;418:120–133.
   PubMed Web of Science ®Google Scholar
• Lee Y, Dang JT, Switzer N, et al. Impact of bariatric surgery on male sex hormones and sperm quality: a systematic review and meta-analysis. Obes Surg. 2019;29:334–346.
   PubMed Web of Science ®Google Scholar
• Corona G, Rastrelli G, Morgentaler A, et al. Meta-analysis of results of testosterone therapy on sexual function based on international index of erectile function scores. Eur Urol. 2017;72:1000–1011.
   PubMed Web of Science ®Google Scholar
• Snyder PJ, Bhasin S, Cunningham GR, et al. Effects of testosterone treatment in older men. N Engl J Med. 2016;374:611–624.
   PubMed Web of Science ®Google Scholar
• Moura A, Tomada I, Tomada N. The influence of metabolic profile of obese men on the severity of erectile dysfunction: are metabolically healthy obese individuals protected? Türk Üroloji Dergisi/Turkish J Urol. 2018;44:455–461.
   Google Scholar
• Lotti F, Rastrelli G, Maseroli E, et al. Impact of metabolically healthy obesity in patients with andrological problems. J Sex Med. 2019;16:821–832.
   PubMed Web of Science ®Google Scholar
• Choy JT, Eisenberg ML. Male infertility as a window to health. Fertil Steril. 2018;110:810–814.
   PubMed Web of Science ®Google Scholar
• Salonia A, Matloob R, Gallina A, et al. Are infertile men less healthy than fertile men? Results of a prospective casecontrol survey. Eur Urol. 2009;56:1025–1031.
   PubMed Web of Science ®Google Scholar
• Lotti F, Corona G, Castellini G, et al. Semen quality impairment is associated with sexual dysfunction according to its severity. Hum Reprod. 2016;31:2668–2680.
   PubMed Web of Science ®Google Scholar
• Eisenberg ML, Li S, Cullen MR, et al. Increased risk of incident chronic medical conditions in infertile men: analysis of United States claims data. Fertil Steril. 2016;105:629–636.
   PubMed Web of Science ®Google Scholar
• Cazzaniga W, Capogrosso P, Ventimiglia E, et al. High blood pressure is a highly prevalent but unrecognised condition in primary infertile men: results of a cross-sectional study. Eur Urol Focus. 2018:30214–1. pii: S2405–4569.
   Google Scholar
• Jensen TK, Jacobsen R, Christensen K, et al. Good semen quality and life expectancy: a cohort study of 43,277 men. Am J Epidemiol. 2009;170:559–565.
   PubMed Web of Science ®Google Scholar
• Eisenberg ML, Li S, Behr B, et al. Semen quality, infertility and mortality in the USA. Hum Reprod. 2014;29:1567–1574.
   PubMed Web of Science ®Google Scholar
• Latif T, Lindahl-Jacobsen R, Mehlsen J, et al. Semen quality associated with subsequent hospitalizations - Can the effect be explained by socio-economic status and lifestyle factors? Andrology. 2018;6:428–435.
   PubMed Web of Science ®Google Scholar
• MacDonald AA, Herbison GP, Showell M, et al. The impact of body mass index on semen parameters and reproductive hormones in human males: a systematic review with meta-analysis. Hum Reprod Update. 2010;16:293–311.
   PubMed Web of Science ®Google Scholar
• Sermondade N, Faure C, Fezeu L, et al. Obesity and increased risk for oligozoospermia and azoospermia. Arch Intern Med. 2012;172:440–442.
   PubMedGoogle Scholar
• Sermondade N, Faure C, Fezeu L, et al. BMI in relation to sperm count: an updated systematic review and collaborative meta-analysis. Hum Reprod Update. 2013;19:221–231.
   PubMed Web of Science ®Google Scholar
• Le W, Su SH, Shi LH, et al. Effect of male body mass index on clinical outcomes following assisted reproductive technology: a meta-analysis. Andrologia. 2016;48:406–424.
   PubMed Web of Science ®Google Scholar
• Guo D, Wu W, Tang Q, et al. The impact of BMI on sperm parameters and the metabolite changes of seminal plasma concomitantly. Oncotarget. 2017;8:48619–48634.
   PubMedGoogle Scholar
• Mushtaq R, Pundir J, Achilli C, et al. Effect of male body mass index on assisted reproduction treatment outcome: an updated systematic review and meta-analysis. Reprod Biomed Online. 2018;36:459–471.
   PubMed Web of Science ®Google Scholar
• Leisegang K, Udodong A, Bouic PJ, et al. Effect of the metabolic syndrome on male reproductive function: a case-controlled pilot study. Andrologia. 2014;46:167–176.
   PubMed Web of Science ®Google Scholar
• Pilatz A, Hudemann C, Wolf J, et al. Metabolic syndrome and the seminal cytokine network in morbidly obese males. Andrology. 2017;5:23–30.
   PubMed Web of Science ®Google Scholar
• Lotti F, Corona G, Degli Innocenti S, et al. Seminal, ultrasound and psychobiological parameters correlate with metabolic syndrome in male members of infertile couples. Andrology. 2013;1:229–239.
   PubMed Web of Science ®Google Scholar
• Lotti F, Corona G, Vignozzi L, et al. Metabolic syndrome and prostate abnormalities in male subjects of infertile couples. Asian J Androl. 2014;16:295–304.
   PubMed Web of Science ®Google Scholar
• Muciaccia B, Pensini S, Culasso F, et al. Higher cluster in immune labeling and sperm DNA damage levels in hypertensive men compared with controls. Hum Reprod. 2012;27:2267–2276.
   PubMed Web of Science ®Google Scholar
• Mbah AU, Ndukwu GO, Ghasi SI, et al. Low-dose lisinopril in normotensive men with idiopathic oligospermia and infertility: a 5-year randomized, controlled, crossover pilot study. Clin Pharmacol Ther. 2012;91:582–589.
   PubMed Web of Science ®Google Scholar
• Robeva R, Kumanov P. Sperm disturbances in metabolic syndrome: what we actually know. Expert Rev Endocrinol Metab. 2013;8:351–353.
   PubMedGoogle Scholar
• Guo D, Li S, Behr B, et al. Hypertension and male fertility. World J Mens Health. 2017;35:59–64.
   PubMedGoogle Scholar
• Ventimiglia E, Capogrosso P, Colicchia M, et al. Metabolic syndrome in white European men presenting for primary couple’s infertility: investigation of the clinical and reproductive burden. Andrology. 2016;4:944–951.
   PubMed Web of Science ®Google Scholar
• Lotti F, Corona G, Mancini M, et al. Ultrasonographic and clinical correlates of seminal plasma interleukin-8 levels in patients attending an andrology clinic for infertility. Int J Androl. 2011;34:600–613.
   PubMedGoogle Scholar
• Rastrelli G, Vignozzi L, Corona G, et al. Testosterone and benign prostatic hyperplasia. Sex Med Rev. 2019;7:259–271.
   PubMed Web of Science ®Google Scholar
• Inman BA, Sauver JL, Jacobson DJ, et al. A population-based, longitudinal study of erectile dysfunction and future coronary artery disease. Mayo Clin Proc. 2009;84:108–113.
   PubMed Web of Science ®Google Scholar
• Rastrelli G, Corona G, Lotti F, et al. Flaccid penile acceleration as a marker of cardiovascular risk in men without classical risk factors. J Sex Med. 2014;11:173–186.
   PubMed Web of Science ®Google Scholar